Stem-loop sequence hsa-mir-5685

Accession MI0019287
Description Homo sapiens miR-5685 stem-loop
Stem-loop 
                a                 cucc 
cucuacaucacagccc gcaguuaucacgggccc    c
|||||||||||||||| |||||||||||||||||    c
gagauguagugucggg cgucaauagugcccggg    u
                a                 uaac
Get sequence
Genome context
Coordinates (GRCh37.p5) Overlapping transcripts
chr6: 53141791-53141869 [+]
antisense
OTTHUMT00000043566 ; RP3-483K16.1-001; intron 3
OTTHUMT00000043566 ; RP3-483K16.1-001; intron 3
OTTHUMT00000043566 ; RP3-483K16.1-001; intron 3
OTTHUMT00000043570 ; RP3-483K16.1-005; intron 4
OTTHUMT00000043570 ; RP3-483K16.1-005; intron 4
OTTHUMT00000043570 ; RP3-483K16.1-005; intron 4
OTTHUMT00000043568 ; RP3-483K16.1-003; intron 5
OTTHUMT00000043568 ; RP3-483K16.1-003; intron 5
OTTHUMT00000043568 ; RP3-483K16.1-003; intron 5
OTTHUMT00000043569 ; RP3-483K16.1-004; intron 6
OTTHUMT00000043569 ; RP3-483K16.1-004; intron 6
OTTHUMT00000043569 ; RP3-483K16.1-004; intron 6
ENST00000304434 ; ELOVL5-001; intron 3
ENST00000542638 ; ELOVL5-203; intron 3
ENST00000304434 ; ELOVL5-001; intron 3
ENST00000542638 ; ELOVL5-203; intron 3
ENST00000304434 ; ELOVL5-001; intron 3
ENST00000542638 ; ELOVL5-203; intron 3
ENST00000485336 ; ELOVL5-005; intron 4
ENST00000370918 ; ELOVL5-201; intron 4
ENST00000541407 ; ELOVL5-202; intron 4
ENST00000485336 ; ELOVL5-005; intron 4
ENST00000370918 ; ELOVL5-201; intron 4
ENST00000541407 ; ELOVL5-202; intron 4
ENST00000485336 ; ELOVL5-005; intron 4
ENST00000370918 ; ELOVL5-201; intron 4
ENST00000541407 ; ELOVL5-202; intron 4
ENST00000465983 ; ELOVL5-003; intron 5
ENST00000465983 ; ELOVL5-003; intron 5
ENST00000465983 ; ELOVL5-003; intron 5
ENST00000486973 ; ELOVL5-004; intron 6
ENST00000486973 ; ELOVL5-004; intron 6
ENST00000486973 ; ELOVL5-004; intron 6

Mature sequence hsa-miR-5685

Accession MIMAT0022475
Sequence

10 -  

acagcccagcaguuaucacggg

 - 31

Get sequence
Evidence experimental; Solexa [1]
Predicted targets

References

1
PMID:21980368 "MicroRNAs associated with metastatic prostate cancer" Watahiki A, Wang Y, Morris J, Dennis K, O'Dwyer HM, Gleave M, Gout PW, Wang Y PLoS One. 6:e24950(2011).